Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMaastricht University Medical Center

About this trial

Basal cell carcinoma (BCC) is the most common skin cancer in the Netherlands, with incidence rates continuing to rise. The current diagnostic standard combines clinical evaluation and dermoscopy, while biopsy followed by histopathological examination remains the gold standard when uncertainty about the diagnosis persists. However, biopsy is invasive, time-consuming, and costly. Line-field confocal optical coherence tomography (LC-OCT) is a non-invasive imaging technique that has emerged as a promising alternative to biopsy for BCC suspected lesions.

This retrospective study aims to evaluate the real-world clinical performance of LC-OCT in routine dermatological practice, where it has been integrated into the diagnostic work-up for BCC-suspect lesions.

Eligibility criteria

Qualifiers

Patients aged ≥18 years

LC-OCT performed as part of diagnostic evaluation between January 2025 and June 2025 at Mohs clinics in the Netherlands

Histopathological results (biopsy or excision) and/or 6-12 month clinical follow-up data available

Disqualifiers

Patients <18 years of age

Cases without histopathological confirmation or available follow-up data

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

297 Participants
are grouped into 1 trial group

Sponsors and collaborators